PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS SUITABLE FOR TREATING HIV-INFECTED PATIENTS

Compounds of the formula I or Ia Ax[MDLW11O39].yH2O I Ax[D min (MW11O39)2].yH2O Ia in which A is a cation, x is an integer, M is B, Si or P, D is metal and D min is a lanthanide in oxidation state 3 or 4, L is a neutral or anionic ligand, and y is an integer, have anti-viral activity in a standard s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SAVAGE,PAUL DAVID,GB, THEOBALD,BRIAN RONALD CHARLES,GB, MURRER,BARRY ANTHONY,GB
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of the formula I or Ia Ax[MDLW11O39].yH2O I Ax[D min (MW11O39)2].yH2O Ia in which A is a cation, x is an integer, M is B, Si or P, D is metal and D min is a lanthanide in oxidation state 3 or 4, L is a neutral or anionic ligand, and y is an integer, have anti-viral activity in a standard screen, and may be used to produce compositions and also coated articles and devices for treatment or prophylactic treatment of patients at risk.